Biosimilars Forum Says 75% Market Share Could Save US Billions
As AAM Discourages Reducing Incentives For Patent Challenge And Early Generic Entry
• By Akriti Seth
The Biosimilars Forum’s latest study shows state-by-state the cost-saving potential of biosimilars • Source: Alamy 
